Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin for Cerebral Perfusion
NCT05543837Phase 2Completed
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Sep 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of capsaicin in cerebrovascular disease (2 arms), sponsored by Instituto Mexicano del Seguro Social. Primary endpoints: Mean Velocity at 20 minutes and Pulsatility Index at 20 minutes. Started Sep 2022; status: completed.
02
Drugs
capsaicin
03
Conditions
cerebrovascular disease
Beyond the preview
Go deeper on NCT05543837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05543837.